Overview

Apomorphine Effects on Pain in Parkinson's Disease

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
To study the effects of acute apomorphine vs. placebo administration on different Parkinson's disease pain types.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Calgary
Collaborator:
Paladin Labs Inc.
Treatments:
Apomorphine